The management of resistant depression

Acta Psychiatr Belg. 1986 Mar-Apr;86(2):141-51.

Abstract

Between 10 and 30% of depressed patients, mostly bipolar, develop a therapy-resistant illness. The known causes of such chronic evolutions are discussed: misdiagnosis (underlying schizophrenia, personality disorder or dementia), drug-induced depression (neuroleptics), systemic disease (hypothyroidism, multiple sclerosis, cardiovascular or neoplastic disease etc.), or lack of efficacy (drug compliance, insufficient dosage). Remedies are suggested: adequate dosage, drug combination (Newcastle cocktail. tricyclic antidepressant + MAOI, imipramine + T3), carbamazepine in lithium-resistant cases, alprazolam, reduction in vanadium intake, sleep deprivation, psychosurgery.

MeSH terms

  • Antidepressive Agents, Tricyclic / therapeutic use
  • Bipolar Disorder / therapy*
  • Depressive Disorder / diagnosis
  • Depressive Disorder / therapy*
  • Diagnostic Errors
  • Electroconvulsive Therapy
  • Female
  • Humans
  • Lithium / therapeutic use
  • Lithium Carbonate
  • Male
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Psychosurgery
  • Sleep Deprivation
  • Triiodothyronine / therapeutic use

Substances

  • Antidepressive Agents, Tricyclic
  • Monoamine Oxidase Inhibitors
  • Triiodothyronine
  • Lithium Carbonate
  • Lithium